184 related articles for article (PubMed ID: 32740535)
1. Cystic Fibrosis-related Liver Disease: The Next Challenge.
Baker RD; Baker SS
J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):421-422. PubMed ID: 32740535
[TBL] [Abstract][Full Text] [Related]
2. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
Staufer K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis-associated liver disease in children.
Wasuwanich P; Karnsakul W
Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
[TBL] [Abstract][Full Text] [Related]
7. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
Scott J; Jones AM; Piper Hanley K; Athwal VS
Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary complications of cystic fibrosis.
Feranchak AP
Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
[TBL] [Abstract][Full Text] [Related]
9. Animal models for cystic fibrosis liver disease (CFLD).
Fiorotto R; Amenduni M; Mariotti V; Cadamuro M; Fabris L; Spirli C; Strazzabosco M
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):965-969. PubMed ID: 30071276
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation.
Shen H; Fan Y; Yang X; Burczynski FJ; Li P; Gong Y
J Cell Physiol; 2005 Jun; 203(3):599-603. PubMed ID: 15605366
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis modifier genes.
Davies J; Alton E; Griesenbach U
J R Soc Med; 2005; 98 Suppl 45(Suppl 45):47-54. PubMed ID: 16025767
[TBL] [Abstract][Full Text] [Related]
12. Emerging clinical perspectives in cystic fibrosis liver disease.
Athwal VS; Scott JA; Fitzpatrick E; Rowland M
Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
[TBL] [Abstract][Full Text] [Related]
13. [Question 5. What management of hepatobiliary injury in the course of cystic fibrosis? Physiopathology and diagnostic criteria of hepatobiliary injury in the course of cystic fibrosis].
Belli DC
Arch Pediatr; 2003 Aug; 10 Suppl 3():487s-489s. PubMed ID: 14671964
[No Abstract] [Full Text] [Related]
14. Cystic Fibrosis Liver Disease: Know More.
Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
[TBL] [Abstract][Full Text] [Related]
15. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
Boëlle PY; Debray D; Guillot L; Clement A; Corvol H;
Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245
[TBL] [Abstract][Full Text] [Related]
16. The natural history of cystic fibrosis liver disease a prospective cohort study.
Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
[TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing and managing advanced liver disease in cystic fibrosis.
Palaniappan SK; Than NN; Thein AW; van Mourik I
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012056. PubMed ID: 32227478
[TBL] [Abstract][Full Text] [Related]
18. Liver disease in patients with cystic fibrosis.
Kamal N; Surana P; Koh C
Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
[TBL] [Abstract][Full Text] [Related]
19. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis liver disease in children - A review of our current understanding.
Costaguta G; Patey N; Álvarez F
Arch Argent Pediatr; 2023 Aug; 121(4):e202202905. PubMed ID: 36856762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
